Surveillance and Control Strategies to Fight Mosquito-Borne Diseases

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Viral Pathogens".

Deadline for manuscript submissions: 31 January 2025 | Viewed by 1807

Special Issue Editors


E-Mail Website
Guest Editor
Biotechnology and Agroindustry Division, ENEA Casaccia Research Center, Via Anguillarese, 301, Santa Maria di Galeria, 00123 Roma, Italy
Interests: vector control; Wolbachia transinfection; incompatible insect technique; insect biotechnology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

Arboviruses (arthropod-borne viruses) represent a continuous menace for human health, and global change is supporting their emergence in new areas and re-emergence even where they seemed under control. A major role in recent outbreaks of arboviral diseases is certainly played by mosquitoes, mainly due to their capacity to rapidly acquire resistance against several insecticides and to their remarkable dispersal ability and adaptability to perturbed and urbanized lands. The recent outbreaks of important diseases like dengue, Zika, chikungunya, yellow fever, West Nile fever, and Rift Valley fever are a clear demonstration of the urgency of renewed efforts to fight this burden. Additionally, key vector mosquitoes like Aedes albopictus and Ae. aegypti are spreading across temperate climate areas and are supporting several documented cases of autochthonous transmission of viral diseases that were once only restricted to the tropics. Facing this threat necessitates a reinforcement of the surveillance system and innovations in the sector of control strategies together with a coordinated action by all the actors involved in disease prevention and control, including governments, public and private organizations, and local communities.

In this regard, a Global Vector Control Response (GVCR) 2017–2030 and a Global Arbovirus Initiative (GLAI) have been launched by the WHO to outline the key priority actions to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination, and integrated action across sectors and diseases, as well as taking into account criteria of sustainability.

Research has the role of contributing to this effort by providing the data that are necessary for evidence-informed decision making.

In this context, this Special Issue aims to collect a series of original research articles or reviews related to three specific topics:

  1. Mosquito surveillance (ecology, biodiversity, transmission, and resistance)
  2. Emerging mosquito-borne diseases
  3. Control strategies (with particular attention paid to highly specific and environmentally safe bio-control strategies such as sterile male-based suppression, larval control through insect growth regulators (IGRs) and Bti, bacteria to reduce the vector competence of key mosquito vectors, use of aquatic predators, etc.)

Dr. Riccardo Moretti
Dr. Marta Giovanetti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • arboviral diseases
  • mosquitoes
  • surveillance
  • control

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 519 KiB  
Article
Pre-or co-SARS-CoV-2 Infections Significantly Increase Severe Dengue Virus Disease Criteria: Implications for Clinicians
by Moeen Hamid Bukhari, Esther Annan, Ubydul Haque, Pedro Arango, Andrew K. I. Falconar and Claudia M. Romero-Vivas
Pathogens 2024, 13(7), 573; https://doi.org/10.3390/pathogens13070573 - 10 Jul 2024
Cited by 1 | Viewed by 1263
Abstract
Few studies have investigated whether SARS-CoV-2 infections increase the incidence of dengue haemorrhagic fever/shock syndrome (DHF/DSS) and/or severe dengue (SD) in dengue virus (DENV)-infected patients. This study was performed on a site with high incidences of classical dengue, but relatively few DHF/DSS or [...] Read more.
Few studies have investigated whether SARS-CoV-2 infections increase the incidence of dengue haemorrhagic fever/shock syndrome (DHF/DSS) and/or severe dengue (SD) in dengue virus (DENV)-infected patients. This study was performed on a site with high incidences of classical dengue, but relatively few DHF/DSS or SD cases as defined by the WHO 1997 or 2009 criteria, respectively. Clinical, haematological/biochemical, and viral diagnostic data were collected from febrile patients before, during, and after the COVID-19 epidemic to assess whether (a) DENV-infected patients with prior SARS-CoV-2 infections or (b) DENV-SARS-CoV-2-co-infected patients had increased incidences of SD/DHF/DSS using logistic regression and machine learning models. Higher numbers of DHF/DSS/SD occurred during the COVID-19 epidemic, particularly in males and 18–40-year-olds. Significantly increased symptoms in the DENV-SARS-CoV-2-co-infected cases were (a) haemoconcentration (p < 0.0009) and hypotension (p < 0.0005) (DHF/DSS and SD criteria), (b) thrombocytopenia and mucosal bleeding (DHF/DSS-criteria), (c) abdominal pain, persistent vomiting, mucosal bleeding, and thrombocytopenia (SD warning signs) and (d) dyspnoea, but without fluid accumulation. DENV-infected patients with prior SARS-CoV-2 infections had significantly increased incidences of thrombocytopenia (DHF/DSS-criteria) and/or abdominal pain and persistent vomiting and also thrombocytopenia (SD warning signs), but without significant haemoconcentration or hypotension. DENV-SARS-CoV-2 co-infections significantly increased the incidence of DHF/DSS/SD, while DENV-infected patients with prior SARS-CoV-2 infections displayed significantly increased incidences of thrombocytopenia (DHF/DSS-criteria) and three important SD warning signs, which are therefore very important for health workers/clinicians in assessing patients’ DHF/DSS/SD risk factors and planning their optimal therapies. Full article
(This article belongs to the Special Issue Surveillance and Control Strategies to Fight Mosquito-Borne Diseases)
Show Figures

Figure 1

Back to TopTop